missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human CEP85L (aa 112-185) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (78%), Rat (78%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-56070 (PA5-56070. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
The protein encoded by this gene was identified as a breast cancer antigen. Nothing more is known of its function at this time. Three transcript variants encoding different isoforms have been found for this gene.
Specifications
Specifications
| Accession Number | Q5SZL2 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 387119 |
| Name | Human CEP85L (aa 112-185) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | bA57K17.2; C1H6orf204; C6orf204; centrosomal protein 85 like; centrosomal protein 85 kDa-like; centrosomal protein 85-like; centrosomal protein of 85 kDa-like; CEP85L; coiled-coil domain-containing c6orf204-like protein; ENSMUSG00000038594; Gm9766; LOW QUALITY PROTEIN: centrosomal protein of 85 kDa-like; NY-BR-15; rCG22129-like; serologically defined breast cancer antigen NY-BR-15 |
| Common Name | CEP85L |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction